Sanofi Share Price Euronext Paris
Stocks
SANNV
FR0014013QA3
Pharmaceuticals
OTC Markets Traded| Market Cap | 8.88TCr 9.94TCr 8.2TCr 7.43TCr 14TCr 9,44000Cr 14TCr 99TCr 39TCr 4,94600Cr 37TCr 37TCr 15,59300Cr | P/E 2026 * |
11.8x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 10TCr 11TCr 9.25TCr 8.38TCr 16TCr 10,64500Cr 16TCr 1,11300Cr 44TCr 5,57700Cr 42TCr 41TCr 17,58400Cr | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.91x |
| Free-Float |
88.34% | Yield 2026 * |
5.76% | Yield 2027 * | 6.08% |
Last Transcript: Sanofi
| 1 day | +6.12% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.12% | -1.27% | - | - | 9.94TCr | |
| -2.54% | +1.31% | +54.27% | +117.14% | 1,13500Cr | |
| -1.42% | +3.23% | +38.56% | +74.05% | 64TCr | |
| +0.16% | +0.08% | +25.29% | +96.64% | 50TCr | |
| -0.31% | +3.09% | +44.14% | +64.55% | 38TCr | |
| -1.34% | -0.47% | +66.04% | +40.18% | 36TCr | |
| -0.68% | +2.65% | +22.98% | +49.15% | 29TCr | |
| -1.20% | +3.04% | +2.33% | +21.60% | 27TCr | |
| -1.79% | +1.57% | +50.56% | +61.40% | 24TCr | |
| -0.73% | -0.10% | +29.02% | +99.06% | 19TCr | |
| Average | -0.37% | +1.60% | +37.02% | +69.31% | 44.49TCr | |
| Weighted average by Cap. | -1.16% | +1.63% | +41.02% | +80.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.76TCr 5.33TCr 4.39TCr 3.98TCr 7.45TCr 5,05600Cr 7.57TCr 53TCr 21TCr 2,64900Cr 20TCr 20TCr 8,35200Cr | 5.07TCr 5.67TCr 4.68TCr 4.24TCr 7.93TCr 5,38500Cr 8.07TCr 56TCr 22TCr 2,82200Cr 21TCr 21TCr 8,89500Cr |
| Net income | 767.03Cr 858.94Cr 708.59Cr 642.14Cr 1.2TCr 82TCr 1.22TCr 8.53TCr 3.38TCr 43TCr 3.22TCr 3.15TCr 1,34700Cr | 907.32Cr 1.02TCr 838.19Cr 759.59Cr 1.42TCr 96TCr 1.44TCr 10TCr 3.99TCr 51TCr 3.81TCr 3.73TCr 1,59300Cr |
| Net Debt | 1.13TCr 1.27TCr 1.05TCr 949.14Cr 1.78TCr 1,20500Cr 1.81TCr 13TCr 4.99TCr 63TCr 4.76TCr 4.66TCr 1,99100Cr | 800.45Cr 896.36Cr 739.46Cr 670.12Cr 1.25TCr 85TCr 1.27TCr 8.9TCr 3.52TCr 45TCr 3.36TCr 3.29TCr 1,40600Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
